GENOWAY revenue breakdown overview

GENOWAY revenue for the last year amounted to 20.10 M EUR, the most of which — 20.05 M EUR — came from its highest performing source at the moment, Genetically Modified Mice, Rats, and Cell Lines, the year earlier bringing 17.05 M EUR. The greatest contribution to the revenue figure was made by France — last year it brought GENOWAY 20.05 M EUR, and the year before that — 17.05 M EUR.